Antiepileptic drugs influences on body weight in people with epilepsy

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Expert Review of Clinical Pharmacology

• Publication date

  2015-01-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1586/17512433.2015.991716PMID 25487080
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Obesity and its association with generalised epilepsy, idiopathic syndrome, and family history of epilepsy.

  2014cited by this paper
• Coinfusion of Low-Dose GLP-1 and Glucagon in Man Results in a Reduction in Food Intake

  2014cited by this paper
• Atherosclerosis in epilepsy: its causes and implications.

  2014cited by this paper
• The endocannabinoid system controls food intake via olfactory processes

  2014cited by this paper
• Serum, urine, and saliva levels of ghrelin and obestatin pre- and post-treatment in pediatric epilepsy.

  2014cited by this paper
• The effect of topiramate on body weight and ghrelin, leptin, and neuropeptide-Y levels of prepubertal children with epilepsy.

  2014cited by this paper
• Obesity in adults with epilepsy.

  2013cited by this paper
• Cocaine- and amphetamine-regulated transcript (CART) peptide immunoreactivity in feeding- and reward-related brain areas of young OLETF rats.

  2013cited by this paper
• The effects of topiramate and valproate therapy on insulin, c-peptide, leptin, neuropeptide Y, adiponectin, visfatin, and resistin levels in children with epilepsy.

  2013cited by this paper
• Dramatic weight loss with rufinamide

  2013cited by this paper
• Changes in cardiovascular risk associated with phentermine and topiramate extended-release in participants with comorbidities and a body mass index ≥27 kg/m(2).

  2013cited by this paper
• Effect of Topiramate on Weight Gain in Patients Receiving Atypical Antipsychotic Agents

  2013cited by this paper
• Pharmacological management of binge eating disorder: current and emerging treatment options

  2012cited by this paper
• Low serum leptin level is associated with zonisamide-induced weight loss in overweight female epilepsy patients.

  2012influential reference
• Plasma leptin, neuropeptide Y, ghrelin, and adiponectin levels and carotid artery intima media thickness in epileptic children treated with valproate

  2012cited by this paper
• Zonisamide for weight reduction in obese adults: a 1-year randomized controlled trial.

  2012influential reference
• Weight-reducing side effects of the antiepileptic agents topiramate and zonisamide.

  2012cited by this paper
• Characterizing and understanding body weight patterns in patients treated with pregabalin

  2012cited by this paper
• Long-lasting remission of type 1 diabetes following treatment with topiramate for generalized seizures

  2012cited by this paper
• Weight change associated with antiepileptic drugs

  2012influential reference
• Adjunctive pregabalin for uncontrolled partial‐onset seizures: findings from a prospective audit

  2011influential reference
• Serum Insulin, Cortisol, Leptin, Neuropeptide Y, Galanin and Ghrelin Levels in Epileptic Children Receiving Valproate

  2011cited by this paper
• Ghrelin levels are reduced in prepubertal epileptic children under treatment with carbamazepine or valproic acid

  2010cited by this paper
• Carbonic anhydrase inhibitors. Identification of selective inhibitors of the human mitochondrial isozymes VA and VB over the cytosolic isozymes I and II from a natural product-based phenolic library.

  2010cited by this paper
• Weight Reducing and Metabolic Effects of Topiramate in Patients with Migraine – an Observational Study

  2010cited by this paper
• States of serum leptin and insulin in children with epilepsy: risk predictors of weight gain.

  2009cited by this paper
• The impact of zonisamide on weight. A clinical study in 103 patients with epilepsy

  2009cited by this paper
• The effect of carbamazepine treatment on serum leptin levels.

  2009influential reference
• Six months of postmarketing experience with adjunctive lacosamide in patients with pharmacoresistant focal epilepsy at a tertiary epilepsy center in Germany.

  2009cited by this paper
• Lamotrigine in the treatment of binge-eating disorder with obesity: a randomized, placebo-controlled monotherapy trial

  2009cited by this paper
• Weight gain in bipolar disorder: pharmacological treatment as a contributing factor

  2008influential reference
• Topiramate and Type 2 diabetes: an old wine in a new bottle

  2008cited by this paper
• A Prospective Study of Body Weight and Serum Leptin Levels in Patients Treated With Topiramate

  2008cited by this paper
• Dramatic Weight Loss with Levetiracetam

  2008cited by this paper
• Zonisamide Prevents Olanzapine-Associated Hyperphagia, Weight Gain, and Elevated Blood Glucose in Rats

  2008cited by this paper
• The reproductive conditions and lipid profile in females with epilepsy

  2007cited by this paper
• Topiramate, nutrition and weight change: a prospective study

  2007cited by this paper
• [Oxcarbazepine in the treatment of epilepsy].

  2007cited by this paper
• [Changes of body weight and galanin in epileptic children treated with topiramate].

  2007cited by this paper
• The effect of topiramate on energy balance in obese men: a 6-month double-blind randomized placebo-controlled study with a 6-month open-label extension

  2007cited by this paper
• Effectiveness and weight effects of open-label lamotrigine with and without concomitant psychotropic medications in patients with bipolar I disorder.

  2007cited by this paper
• Leptin and insulin homeostasis in epilepsy: relation to weight adverse conditions.

  2007cited by this paper
• Valproate, weight gain and carbohydrate craving: a gender study.

  2007cited by this paper
• Vascular risk factors and oxidative stress as independent predictors of asymptomatic atherosclerosis in adult patients with epilepsy.

  2007cited by this paper
• The TRH neuron: a hypothalamic integrator of energy metabolism.

  2006cited by this paper
• Impact of lamotrigine and lithium on weight in obese and nonobese patients with bipolar I disorder.

  2006cited by this paper
• Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasis

  2006cited by this paper
• Characterization of Insulin Secretion in Valproate‐treated Patients with Epilepsy

  2006cited by this paper
• The messenger RNA profiles in liver, hypothalamus, white adipose tissue, and skeletal muscle of female Zucker diabetic fatty rats after topiramate treatment.

  2006cited by this paper
• Mortality and cardiac and vascular outcomes in extremely obese women.

  2006cited by this paper
• Gewichtsveränderungen unter Therapie mit Psychopharmaka

  2006cited by this paper
• Chronic Valproic Acid Treatment Triggers Increased Neuropeptide Y Expression and Signaling in Rat Nucleus Reticularis Thalami

  2006cited by this paper
• Effects of lamotrigine and lithium on body weight during maintenance treatment of bipolar I disorder.

  2006cited by this paper
• Serum thyroid hormone balance and lipid profile in patients with epilepsy.

  2005cited by this paper
• Drug-induced weight gain

  2005cited by this paper
• Add-on topiramate reduces weight in overweight patients with affective disorders: a clinical case series

  2005cited by this paper
• Weight variations in the prophylactic therapy of primary headaches: 6–month follow–up

  2005cited by this paper
• [Psychotropic drug-induced change of weight: a review].

  2005cited by this paper
• Leptin, ghrelin, and adiponectin in epileptic patients treated with valproic acid

  2005cited by this paper
• The high atherosclerotic risk among epileptics: the atheroprotective role of multivitamins.

  2005cited by this paper
• Serum Insulin, Leptin, and Neuropeptide Y Levels in Epileptic Children Treated With Valproate

  2005cited by this paper
• Topiramate treatment in bulimia nervosa patients: a randomized, double-blind, placebo-controlled trial.

  2005cited by this paper
• Immunogold study of effects of prenatal exposure to lipopolysaccharide and/or valproic acid on the rat blood-brain barrier vessels

  2005cited by this paper
• Trace elements and electrolytes homeostasis and their relation to antioxidant enzyme activity in brain hyperexcitability of epileptic patients.

  2004cited by this paper
• A randomized double-blind placebo-controlled study of the long-term efficacy and safety of diethylpropion in the treatment of obese subjects

  2004cited by this paper
• Valproate therapy and nonalcoholic fatty liver disease

  2004cited by this paper
• Amygdaloid kindled seizures induce weight gain that reflects left hemisphere dominance in rats.

  2004cited by this paper
• Additive effects of leptin and topiramate in reducing fat deposition in lean and obese ob/ob mice.

  2004cited by this paper
• Obesity and Plasma Concentrations of Alpha-Tocopherol and Beta-Carotene in Epileptic Girls Treated with Valproate

  2004cited by this paper
• Valproate potentiates androgen biosynthesis in human ovarian theca cells.

  2004cited by this paper
• Blood levels of trace elements, electrolytes, and oxidative stress/antioxidant systems in epileptic patients.

  2004cited by this paper
• Hypothalamic control of energy balance.

  2004cited by this paper
• Valproic acid inhibits leptin secretion and reduces leptin messenger ribonucleic acid levels in adipocytes.

  2004cited by this paper
• A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects

  2004cited by this paper
• Topiramate: long-term maintenance of weight loss induced by a low-calorie diet in obese subjects.

  2004cited by this paper
• Predictors of weight loss in adults with topiramate-treated epilepsy.

  2003influential reference
• Insulin and leptin revisited: adiposity signals with overlapping physiological and intracellular signaling capabilities.

  2003cited by this paper
• Effect of Antiepileptic Drugs on Bodyweight

  2003influential reference
• Topiramate Normalizes Hippocampal NPY-LI in Flinders Sensitive Line ‘Depressed’ Rats and Upregulates NPY, Galanin, and CRH-LI in the Hypothalamus: Implications for Mood-Stabilizing and Weight Loss-Inducing Effects

  2003cited by this paper
• Valproic acid-associated weight gain in older children and teens with epilepsy.

  2003cited by this paper
• Levetiracetam does not alter body weight: analysis of randomized, controlled clinical trials.

  2003cited by this paper
• A Putative Relationship between Valproic Acid and Polycystic Ovarian Syndrome: Implications for Treatment of Women with Seizure and Bipolar Disorders

  2003cited by this paper
• Drug points: Weight loss associated with levetiracetam.

  2003cited by this paper
• Valproic acid modulates islet cell insulin secretion: a possible mechanism of weight gain in epilepsy patients.

  2003cited by this paper
• Leptin in the CNS: much more than a satiety signal.

  2003cited by this paper
• Obesity and pharmacologic therapy.

  2003cited by this paper
• Lamotrigine Versus Valproate Monotherapy—Associated Weight Change in Adolescents With Epilepsy: Results From a Post Hoc Analysis of a Randomized, Double-Blind Clinical Trial

  2003cited by this paper
• Higher androgens and weight gain with valproate compared with lamotrigine for epilepsy.

  2003cited by this paper
• Lipotoxic diseases.

  2002cited by this paper
• Leptin inhibits epileptiform‐like activity in rat hippocampal neurones via PI 3‐kinase‐driven activation of BK channels

  2002cited by this paper
• Characterizaton of short isoforms of the leptin receptor in rat cerebral microvessels and of brain uptake of leptin in mouse models of obesity.

  2002cited by this paper
• Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin

  2002cited by this paper
• Serum Insulin and Leptin Levels in Valproate‐associated Obesity

  2002cited by this paper
• Insulin Resistance in Epileptic Girls Who Gain Weight After Therapy With Valproic Acid

  2002influential reference
• Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans.

  2002cited by this paper
• Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes.

  2002cited by this paper
• Adolescent Issues in Epilepsy

  2002cited by this paper
• Effects of free fatty acids on beta-cell functions: a possible involvement of peroxisome proliferator-activated receptors alpha or pancreatic/duodenal homeobox.

  2001cited by this paper
• Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus

  2001cited by this paper
• On the Association Between Valproate and Polycystic Ovary Syndrome: A Response and an Alternative View

  2001cited by this paper

• High prevalence of obesity and reduced physical activity among people with epilepsy: A single-centre cross-sectional study.

  2025cites this paper
• Epilepsy–heart syndrome: Concept, clinical context, and opportunity for integrated care

  2025cites this paper
• Cenobamate‐associated weight loss (Cenobaweight study)

  2025cites this paper
• Antiepileptic and Neuroprotective Biochemical Actions of Sabinene Prevent the Development of Pentylenetetrazol-Induced Seizures and Neuropsychiatric Comorbidities in Mice

  2025cites this paper
• Exploring the causal effects of epilepsy and its subtypes on anthropometric traits: A 2-sample Mendelian randomization study

  2025cites this paper
• GNB1 and obesity: Evidence for a correlation between haploinsufficiency and syndromic obesity

  2024cites this paper
• Is there any concern of insulin resistance and metabolic dysfunctions with antiseizure medications? A prospective comparative study of valproate vs. levetiracetam.

  2024cites this paper
• Liver at crossroads: unraveling the links between obesity, chronic liver diseases, and the mysterious obesity paradox

  2024cites this paper
• Obesity and Metabolic Syndrome in Patients with Epilepsy, their Relation with Epilepsy Control

  2023cites this paper
• Narrative Review of Topiramate: Clinical Uses and Pharmacological Considerations.

  2023cites this paper
• Comparison of the Hepatotoxicity of Carbamazepine, Sodium Valproate, Phenytoin, Lamotrigine, and Vigabatrin in a Rat Model

  2022cites this paper
• Comparison of the Effects of Sodium Valproate and Carbamazepine on Renal Function in Children With Epilepsy

  2022cites this paper
• Exploring correlation between social determinants and overweight/obesity in children and youths with epilepsy

  2022cites this paper
• Polycystic ovary syndrome and the new antiepileptic drugs: A systematic review.

  2022cites this paper
• Incidence of the Metabolic Syndrome among Patients with Epilepsy Attending a Neuropsychiatric Hospital in Kigali, Rwanda

  2021cites this paper
• Médicaments et prise de poids

  2021cites this paper
• Metabolic Alterations Predispose to Seizure Development in High-Fat Diet-Treated Mice: the Role of Metformin

  2020cites this paper
• A pragmatic algorithm to select appropriate antiseizure medications in patients with epilepsy

  2020cites this paper
• Valproate-Induced Epigenetic Upregulation of Hypothalamic Fto Expression Potentially Linked with Weight Gain

  2020cites this paper
• Identifying underlying medical causes of pediatric obesity: Results of a systematic diagnostic approach in a pediatric obesity center

  2020cites this paper
• Drug treatments in patients with cardiac diseases and epilepsy

  2020cites this paper
• Weight Management in Primary Care for Children With Autism: Expert Recommendations

  2020cites this paper
• Physical exercise and seizure activity.

  2020cites this paper
• Cardiometabolic risk and effectiveness of the modified Atkins Ketogenic Diet for adult patients with pharmacoresistant epilepsies in a middle-income country.

  2020cites this paper
• Overview and Management of Childhood Obesity

  2020cites this paper
• Epilepsy and aging.

  2019cites this paper
• Ocular dysfunctions and toxicities induced by antiepileptic medications: Types, pathogenic mechanisms, and treatment strategies

  2019cites this paper
• Weight and Height in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Longitudinal Database Study Assessing the Impact of Guanfacine, Stimulants, and No Pharmacotherapy

  2019cites this paper
• Short-term effects of Garcinia cambogia extract on the pharmacokinetics of lamotrigine given as a single-dose in Wistar rats.

  2019cites this paper
• Importance of Simultaneous Treatment of Obesity and Diabetes Mellitus: A Sequelae to the Understanding of Diabesity-A Review

  2019cites this paper
• Low body mass index and low intelligence quotient are infection risk factors in vagus nerve stimulation.

  2019cites this paper
• Peripheral and central auditory function in adults with epilepsy and treated with carbamazepine

  2019cites this paper
• Urinary volatile metabolites of amygdala-kindled mice reveal novel biomarkers associated with temporal lobe epilepsy

  2019cites this paper
• Overweight and eating disorders in people with epilepsy

  2019cites this paper
• Prevalence and factors associated with overweight and obesity among Spanish students attending special education schools.

  2019cites this paper
• Prenatal Exposure to Oxcarbazepine Increases Hippocampal Apoptosis in Rat Offspring.

  2019cites this paper
• Evaluation of the effects of Citrus aurantium (bitter orange) extract on lamotrigine pharmacokinetics: Insights from in vivo studies in rats.

  2018cites this paper
• Role of Physical Activity and Exercise in Alleviating Cognitive Impairment in People With Epilepsy.

  2018cites this paper
• Schlaf und Epilepsie

  2018cites this paper
• Cochlear Function in Adults with Epilepsy and Treated with Carbamazepine

  2018cites this paper
• Renal dysfunctions/injury in adult epilepsy patients treated with carbamazepine or valproate

  2018cites this paper
• Review of Childhood Obesity: From Epidemiology, Etiology, and Comorbidities to Clinical Assessment and Treatment

  2017cites this paper
• The effect of antiepileptic drugs on the kidney function and structure

  2017cites this paper
• The auditory and vestibular toxicities induced by antiepileptic drugs

  2017cites this paper
• Obesity and Type 2 Diabetes: Two Diseases with a Need for Combined Treatment Strategies - EASO Can Lead the Way

  2017cites this paper
• Vestibular Function in Adults With Epilepsy of Unknown Etiology.

  2017cites this paper
• Paradigm Shifts in the Neuropsychology of Epilepsy

  2017cites this paper
• Fatty liver in adults receiving antiepileptic medications: relationship to the metabolic risks

  2016cites this paper
• Weight gain in children on oxcarbazepine monotherapy.

  2016cites this paper
• The effect of epilepsy and antiepileptic drugs on sexual, reproductive and gonadal health of adults with epilepsy

  2016cites this paper
• Overweight in epilepsy as a risk factor for pregnancy and delivery complications

  2016influential citation
• Music therapy as a non-pharmacological treatment for epilepsy

  2015cites this paper
• The effect of antiepileptic drugs on thyroid hormonal function: causes and implications

  2015cites this paper